Based on our data and published literature, we propose that blocking of P2RY6-mediated signaling can indeed reduce neuroinflammation and might induce HSP expression and CMA activity (Figure 5), which are all considered advantageous during neurodegenerative diseases (49–52). This evidence concerns the gene HSP90B2P and neurodegenerative disease.